PARACETAMOL , FEXOFENADINE , CETIRIZINE , DEXAMETHASONE , mRNA-3745, DIPHENHYDRAMINE , CARBOHYDRATES , IBUPROFEN , HYDROXYZINE , FAMOTIDINE , Isotonische Kochsalzlösung Fresenius, Infusionslösung, ONDANSETRON
mRNA-3745-P102
Phase 2 small_molecule active
Quick answer
PARACETAMOL , FEXOFENADINE , CETIRIZINE , DEXAMETHASONE , mRNA-3745, DIPHENHYDRAMINE , CARBOHYDRATES , IBUPROFEN , HYDROXYZINE , FAMOTIDINE , Isotonische Kochsalzlösung Fresenius, Infusionslösung, ONDANSETRON for Glycogen storage disease type 1a (GSD1a) is a Phase 2 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moderna Biotech Spain
- Indication
- Glycogen storage disease type 1a (GSD1a)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active